Discover 2,440 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,440
Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
for
Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT05389423
Phase 1, Recruiting
A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.
for
Diffuse Large B Cell Lymphoma, Lymphoma, Non-Hodgkin
Location: Baltimore MD, Randallstown MD
Sponsor: The Alvin and Lois Lapidus Cancer Institute
Sex: All
Age: 18+
Code: NCT00333008
Phase 2, Recruiting
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
for
Hematologic Neoplasms
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12 - 70+
Code: NCT05327023
Phase 1, Phase 2, Recruiting
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT06364423
Phase 1, Phase 2, Recruiting
CHIP/CCUS Natural History Protocol
for
Clonal Hematopoiesis of Indeterminate Potential,
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sex: All
Age: 18 - 70+
Code: NCT04102423
Recruiting
Caregiving Networks Across Disease Context and the Life Course
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
for
Solid Tumors, GI Cancer
Location: Boston MA, Baltimore MD, Washington DC, Durham NC,
Sponsor: Curegenix Inc.
Sex: All
Age: 18+
Code: NCT02675946
Phase 1, Recruiting
Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis
for
Psoriasis
Location: Rockville MD
Sponsor: Washington Dermatology Center
Sex: All
Age: 18+
Code: NCT03453190
Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Halifax, Boston MA, The Bronx NY, New York NY,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase 2, Recruiting
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
for
Lymphangioleiomyomatosis
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sex: Female
Age: 18 - 70+
Code: NCT01799538
Phase 1, Phase 2, Recruiting
Efficacy of Extended-Release Liposomal Bupivacaine for Post-Operative Urogynecologic Surgery
for
Postoperative Pain
Location: Bethesda MD
Sponsor: Walter Reed National Military Medical Center